eClinical Solutions
The Product Support Engineer II provides first-level technical assistance to eClinical Solutions' elluminate® clients, focusing on identifying, researching, and resolving user issues. This role involves managing the support ticket lifecycle, communicating directly with customers, and ensuring timely resolutions within defined service level agreements. The position requires quick learning of various applications and technologies to drive customer satisfaction and support user adoption.
Headquarters
Mansfield, Massachusetts, United States
Company Size
201-500 employees
Founded
2012
eClinical Solutions unifies people, data, and AI to support clinical research with purpose-built clinical data software and clinical biometrics services. They combine an integrated technology platform with expert biometrics teams (data management, biostatistics/statistical programming, and data science) to help sponsors and CROs generate high‑quality, regulatory‑compliant trial data. Their solutions focus on accelerating decision‑making and shortening development timelines through automation, analytics, and scalable clinical operations.
eClinical Solutions Appoints Lauren Whitsell as COO and Venu Mallarapu as Chief Transformation and AI Officer
17 hours ago
eClinical Solutions Highlights 2025 Achievements and Announces Latest Innovations to Accelerate and Future-Proof Clinical Trials
2 weeks ago
RealTime eClinical Solutions Wins Awards for Innovation and Brand Strategy
Sep 26, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for eClinical Solutions.
eClinical Solutions didn’t post a salary, so this is our estimate from similar listings.
US eClinical Solutions Market Size & Growth Forecast to 2030
Jan 5, 2026